A clinical trial involving nearly 26,000 people showed these widely taken supplements don't affect rates of cancer diagnosis or serious heart issues but do appear to stem heart attacks and cancer deaths.
A company is marketing a drug intended as a preventive for people at risk for heart disease with stunning statistics but has not yet released details of its study.